Business Context and Reporting Period
Company: Utah Medical Products, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 25, 2024
Reporting Period Covered: Three and six months ended June 30, 2024
This filing serves as a current report to furnish financial information and forward-looking statements for the periods ended June 30, 2024, as detailed in a press release dated July 25, 2024 (Exhibit 99.1).
Key Financial Metrics
The Form 8-K text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within Exhibit 99.1 (the press release) but are not explicitly stated in the body of this filing.
Material Changes
The filing text does not provide specific data regarding material changes versus prior comparable periods. It only indicates that such financial information is attached as an exhibit.
Guidance, Outlook, and Risks
- Outlook: The filing incorporates forward-looking statements relating to 2024 and beyond, which are presented in the attached press release (Exhibit 99.1).
- Legal Status of Information: The information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It shall not be deemed incorporated by reference in any other filing under the Securities Act or Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release dated July 25, 2024) for specific revenue, profit, and cash flow figures for the three and six months ended June 30, 2024.
- Verify the specific forward-looking statements and guidance for 2024 contained in the attached exhibit.
- Note that the financial data in this 8-K is furnished but not "filed" under Section 18 of the Exchange Act, which may impact liability considerations.